SIGVARIS Completes Acquisition of BiaCare

WINTERTHUR, Switzerland (August 29, 2016)—SIGVARIS, a manufacturer of graduated compression, is excited to announce it has completed its acquisition of BiaCare’s business, located in Holland, Michican.

Renowned in the industry for innovative medical compression product lines such as CHIPSLEEVE and COMPREFLEX, BiaCare brings to SIGVARIS an assortment of products that have already gained the trust of physicians and therapists worldwide.

“BiaCare has a strong reputation for being a pioneering leader in the design and production of medical short stretch wraps, compression garments and other garments for patients in need of therapy options,” says Scot Dubé, president and CEO for SIGVARIS North America. “We feel that BiaCare’s core product assortment is strongly aligned with SIGVARIS’s commitment of providing the best products in the market in terms of comfort, quality, fit and therapeutic value.”

“The addition of BiaCare products also strengthens SIGVARIS’s market position in both North America and globally by providing an opportunity for SIGVARIS to serve even more patients under a single brand,” Dubé adds.

BiaCare’s advanced line of compression products is designed to treat lymphedema, lipedema and chronic venous insufficiency.

“BiaCare and SIGVARIS are perfectly aligned, not only in our passion to see patients with complex edema have better outcomes and an improved quality of life, but also, in a common culture of teamwork and continuous innovation based on feedback from the patient and clinical communities,” says Dan Karadsheh, vice president of the BiaCare Corporation.

Keith Hoffman, president of the BiaCare Corporation agrees, “BiaCare is excited to become a part of the SIGVARIS family. This acquisition significantly increases our ability to provide physicians and therapists the compression solutions they need, utilizing the well-established SIGVARIS brand.”

Andreas Schönenberger, CEO of the SIGVARIS Group says, “By acquiring BiaCare, the SIGVARIS Group continues its long-term strategy of expanding its product assortment for patients in need of medically-complex therapy options. In this rapidly growing market segment, SIGVARIS will maintain its place as a global leader in terms of both innovation and compression therapy.”

Visit sigvaris.com for more information.